Dr Peter McCullough on Early Treatment vs. Vaccination

There is an emergency need for early ambulatory treatment of Coronavirus Disease 2019 (COVID-19) in acutely ill patients in an attempt to reduce disease progression and the risks of hospitalization and death. Such management should be applied in high-risk patients age > 50 years or with one or mo …

The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly. In-hospital treatment addresses the multifaceted nature of the illness including ...

Geert Vanden Bossche, DMV, PhD, independent virologist and vaccine expert, formerly employed at GAVI and The Bill & Melinda Gates Foundation, sends open call to all authorities, scientists and experts around the world, to whom this concerns: the entire world population.

Tremendous privilege for me to host the first live discussion between two stalwarts in the COVID-19 pandemic. Both men have taken an ethical stand to focus on science and not be afraid to share their expertise. The world now stands at a crossroads again. Where do we plant our next step? Geert Vanden Bossche - Expert vaccine developer (Belgium) Robert Malone MD - Inventor of mRNA vaccines (USA) Time to listen and be open to change. McMillan Research https://mcmillanresearch.com/

AFLDS.org presents SUMMIT SESSIONS: The Science, part of a series of presentations delivering accurate scientific facts, the latest medical research, and sensible health policy solutions, featuring Dr

UMIN, UMIN000033536 . Registered 27 July 2018.

This article may be...

It has been revealed that a central mechanism that reduces the activity of AMPK, paving the way for fat retention and elevated glucose is uric acid.

THE INVESTIGATION INTO COVID-19’S ORIGIN TAKES NEW TWIST Tony Fauci, Peter Daszak, Ralph Baric, the Wuhan Lab, “chimeric” viruses, gain of function research, airborne nanoparticle release…this story has it all as newly discovered documents lay out a shocking roadmap that even DARPA Refused to engage with. Is this the latest smoking gun in the Covid-19 […]

What does the empirical evidence in the peer-reviewed scientific literature say about prevention? How effective is early treatment?

Trehalose is added in drug formulations to act as fillers or improve aerosolization performance. Its characteristics as a carrier molecule have been e…

"If we were to follow the scientific method, as it was taught in textbooks ... we would immediately see this observation of menstrual cycle changes in tens of thousands of women as a signal, for which necessary questions would need to be asked," Dr. Lawrence Palevsky told The Defender

The outbreak of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has led to coronavirus disease-19 (COVID-19); a pandemic disease that has resulted in devastating social, economic, morbidity and mortality burdens. SARS-CoV-2 infects cells ...

AbstractObjectives. As global vaccination campaigns against COVID-19 disease commence, vaccine safety needs to be closely assessed. The safety profile of mRNA-b

The mRNA-based BNT162b2 vaccine from Pfizer/BioNTech was the first registered COVID-19 vaccine and has been shown to be up to 95% effective in preventing SARS-CoV-2 infections. Little is known about the broad effects of the new class of mRNA vaccines, especially whether they have combined effects on innate and adaptive immune responses. Here we confirmed that BNT162b2 vaccination of healthy individuals induced effective humoral and cellular immunity against several SARS-CoV-2 variants. Interestingly, however, the BNT162b2 vaccine also modulated the production of inflammatory cytokines by innate immune cells upon stimulation with both specific (SARS-CoV-2) and non-specific (viral, fungal and bacterial) stimuli. The response of innate immune cells to TLR4 and TLR7/8 ligands was lower after BNT162b2 vaccination, while fungi-induced cytokine responses were stronger. In conclusion, the mRNA BNT162b2 vaccine induces complex functional reprogramming of innate immune responses, which should be considered in the development and use of this new class of vaccines. ### Competing Interest Statement M.G.N and L.A.B.J are scientific founders of Trained Therapeutix and Discovery. ### Clinical Trial EudraCT 2021-000182-33 ### Funding Statement Y.L. was supported by an ERC Starting Grant (#948207) and the Radboud University Medical Centre Hypatia Grant (2018) for Scientific Research. J.D-A. is supported by The Netherlands Organization for Scientific Research (VENI grant 09150161910024). M.G.N. was supported by an ERC Advanced Grant (#833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Arnhem-Nijmegen Institutional Review Board All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes Data from this study are available upon request.

Cole Diagnostics is a dynamic and affordable medical laboratory able to perform blood draws or pathology for patients in the Boise area.

Click here to subscribe - https://www.glutenfreesociety.org/wxrn Ultra Liver Detox: https://www.glutenfreesociety.org/shop/supplements/general-health/ultra-liver-detox/ Lipogest: https://www.glutenfreesociety.org/shop/supplements/general-health/lipogest/ Research has identified a link between celiac disease and liver disease. One large study compared the risk of nonalcoholic fatty liver disease diagnosed from 1997-2009 in over 26,000 individuals with celiac disease to over 130,000 matched reference individuals. Patients with any liver disease prior to celiac disease were excluded, as were individuals with a lifetime diagnosis of alcohol-related disorder to minimize misclassification of nonalcoholic fatty liver disease. The study found that individuals with celiac disease are at increased risk of nonalcoholic fatty liver disease compared to the general population. Excess risks were highest in the first year after celiac disease diagnosis, but persisted through 15 years beyond diagnosis with celiac disease. Another study compared 202 celiac disease patients and 202 control patients and found that more than one-third of CD patients adhering to a GFD had concurrent NAFL, accounting for a three-fold increased risk compared to the general population. Interestingly, this study also found that the relative risk for NAFL was notably higher in non-overweight celiac disease patients To connect with Dr. Osborne visit: On the web: https://drpeterosborne.com/ Facebook: https://www.facebook.com/DoctorPeterOsborne/ Pinterest: https://www.pinterest.com/docosborne/ Instagram: https://www.instagram.com/drosborne Twitter: https://twitter.com/glutenology *These statements have not been evaluated by the Food and Drug Administration. This video is not intended to diagnose, treat, cure or prevent any disease. It is strictly intended for educational purposes only. Additionally, this information is not intended to replace the advice of your physician. Dr. Osborne is not a medical doctor. He does not treat or diagnose disease. He offers nutritional support to people seeking an alternative from traditional medicine. Dr. Osborne is licensed with the Pastoral Medical Association.